Shrestha, R. “Induced Pluripotent Stem Cells Are Japanese Brand Sources for Therapeutic Cells to Pretrial Clinical Research”. Progress in Stem Cell, Vol. 7, no. 1, June 2020, pp. 296-03, doi:https://doi.org/10.15419/psc.v7i1.409.